Documedica S.A.

DOCUMEDICA S.A. is a young and dynamic pharmaceutical Swiss company situated on the banks of Lake of Lugano. Documedica is regularly inspected and approved by Swissmedic and is also regularly inspected by notified bodies such as Istituto Superiore di Sanità, Cermet and DNV for Medical Devices with CE marking and quality system. Documedica is a complete partner, capable of starting from the research and development of a finished product, be it drug, medical device, dietary supplement or cosmetic, up to industrial production and it also deals with regulatory issues related to the registration or certification of a product. Documedica avails itself of qualified distributors for the distribution of its products around the world. Born in 2002, Documedica has in the pipeline 5 CE marked medical devices, 4 dietary supplements and 10 cosmetic products already distributed in some countries within and outside Europe. Documedica is a company that is not afraid of novelty and continues to invest in research and development of innovative products.

Anova healthcare

Innovating Drug Discovery Anova takes results from the best scientific minds and uses the best available technology to bring you the best molecular candidates. You provide the disease, we provide the solution. Anova brings to you the molecule in a sound scientific platform, with data on its activity, multiple preliminary indications based on pathways and historical background information. Our strategy is based on the understanding of the science behind the disease. We then leverage the results of years of positively selected research and use an in-house algorithm for targeting. We provide you the selected candidate and the science behind.

Centre de Diagnostic Radiologique de Carouge

AA Zentivus

AA Zentivus the global pharma industry's innovative and reliable procurement partner. AA Zentivus' attention to service and detail has made us an industry leader. Our core sectors are sourcing and supplying active pharmaceutical ingredients, intermediates and speciality chemicals to pharmaceutical markets globally. We have the strength and extensive supplier base to enable exacting quantities and the highest quality grade products to serve our client base.

Equinox Pharma Ltd

Equinox Pharma is a computationally-driven logic-based drug discovery company which, in partnership with pharma companies, agrochemical companies, biotechs and medicinal chemistry-based contract research organizations, uses its capability in proprietary logic-based machine learning and chemoinformatics (INDDEx™), based on the patented SV-ILP method (Patent number 8126823), to undertake drug discovery programmes for its clients. Equinox Pharma uses its proprietary logic-based machine-learning technique INDDEx™ (Investigational Novel Drug Discovery by Example) to learn from a training dataset of active and inactive molecules from a screening programme to generate quantitative logic-based rules. These rules provide vital chemical insight into the stereochemical and structural requirements for biological activity. Equinox then undertakes ligand-based virtual screening using the logic-based rules to search databases of commercially available, or proprietary, libraries of small molecules to identify potentially active molecules In contrast to other database screening tools, INDDEx™ is unique in the approach used such that the new structures identified, and predicted to be active, can bear little resemblance to the training data molecules. In this way INDDEx™ is a leading tool in scaffold-hopping technology. Reynolds, et al (2012). Assessment of a Rule-Based Virtual Screening Technology (INDDEx) on a Benchmark Data Set. J Phys Chem B 116, 6732-9.